TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04765085

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: comprehensive behavioral intervention therapy (CBIT)
Description: Comprehensive behavioral intervention for tics is an extension of habit reversal training. It includes an expanded set of strategies, such as psycho-education about tic disorders, tic awareness training, competing response training, relaxation training, and functional analysis.~According to the CBIT treatment manual (translated by sun Jinhua and Xu Wen, the author were Douglas W. woods et al., Oxford University Press, New York). The treatments consisted of 8 sessions for 10 weeks The first two phases were 1.5 hours, the last six stages were 1 hour.The treatment process was regularly supervised by a treatment supervisor.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aripiprazole 5Mg Oral Tablet
Description: Considering the patients with chronic tic disorder (chronic motor or vocal tic disorder or Tourette's disorder), aripiprazole was selected as a single drug with constant dose during the treatment. In case of extrapyramidal side effects, benhexol was given to reduce the extrapyramidal side effects, and the dosage and duration of medication were recorded
Study: NCT05081284

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Volume-stable collagen matrix Geistlich Fibro-Gide®
Description: After tooth extraction and implant insertion the Test group will receive a soft tissue augmentation on the buccal side oh the implant. an envelop flap will be raised and a volume-stable collagen graft will be stabilized with sutures.~Control group will not receive soft tissue augmentation.
Study: NCT06385704

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: DMR Procedure
Description: Endoscopic procedure
Study: NCT06419764

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Spleen Invigorating and Weight Reducing Decoction
Description: Composition: Raw Astragalus (Huang Qi) 5g, Cang Zhu 5g, Fructus Aurantii Immaturus (Zhi Shi) 3g, Prepared Rhubarb (Shu Jun) 3g, Red Peony Root (Chi Shao Yao) 3g, Crataegus (Shan Zha) 3g, Tribulus (Bai Jie Li) 2g, Cimicifuga (Sheng Ma) 1g.~Granule form, for oral administration. Take 1 dose daily (2 bags, once in the morning and once in the evening, dissolved in water), for a course of 1 month.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diet and meal replacements
Description: The dietitian provides recommended meal plans based on body weight, and meal replacements are used postoperatively.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Diet and meal replacements
Description: The dietitian provides recommended meal plans based on body weight, and meal replacements are used postoperatively.
Study: NCT05060757

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: biotax
Description: patients who are scheduled to undergo colonoscopy will be asked to participate and give a stool sample
Study: NCT06773572

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Autologous Exososomes procedure obtained from the patients' own platelets.
Description: Intraovarian injection (into the ovarian cortex) was performed over four cycles, once a month in each ovary on days 7, 8, or 9 of the menstrual cycle. Blood was drawn using the selected PRP kit; in this case, all the PRP was placed into two 20 cc syringes, and the exosomes were filtered using the EXOSMAT kit for autologous platelet exosomes. A total of 5 to 6 cc of liquid composed exclusively of platelet-derived exosomes was obtained, with a concentration of 5 to 6 trillion exosomes per milliliter. Finally, 2 to 3 cc were administered to each ovary via the transvaginal route.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Patient group for activated platelet growth factors
Description: the plasma was placed in two 5 cc injectors to place 2 to 3 cc in each ovary (in the ovarian cortex) with the patient sedated. The PRP was placed transvaginally and using a follicular aspiration needle for the PRP group. All biostimulations were performed in early follicular phase (day 7, 8 or 9) in all groups according to their assigned technique.
Study: NCT06269003

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Expert
Description: Participants will view a brief description of an expert source.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Peer
Description: Participants will view a brief description of a peer source.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 1 Sided
Description: Participants will view e-cigarette education messages in two-sided.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 2 Sided
Description: Participants will view e-cigarette education messages in two-sided.
Study: NCT01504282

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: mitomycin-C

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: balanced salt solution (BSS)
Study: NCT06500832

Intervention type: OTHER
Intervention: Survey-based Data Collection Tool
Description: The data collection tool to be presented to the participants is planned as a three-part survey. The first part of this form asked 9 questions about the demographic characteristics of the participants consisted of age, gender, marital status, duration in the profession, specialization in dentistry, type of workplace, and off-the-clock work.~The second part of the data collection tool consisted of the 'Defensive Dentistry Practice Survey,'(DDPS) DDPS which is the original language of which is Turkish, is a 5-point Likert-type scale. A total of 12 statements about DDPS which measure the opinions, attitudes, or behaviors of the participants in terms of DDP, the following options are used: strongly disagreed, disagreed, neither disagreed nor agreed, agreed and strongly agreed, each expressing groups of 20%.~The last part of the survey had 3 close-ended questions with yes-no options expressing 50% groups is used.
Study: NCT06773572

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: the control group
Description: Finally, the control group received 2 to 3 cc of physiological solution in each ovarian cortex for 4 cycles as the two previous groups. All these procedures were performed transvaginally under controlled surgical sedation with follicular aspiration needle in the ovarian cortex and guided by transvaginal echosonogram
Study: NCT05273580

Intervention type: DEVICE
Intervention: Garmin VivoSmart 4
Description: Wearable sensor to record; sleep, stress, heart rate etc.

Intervention type: DEVICE
Intervention: Garmin VivoSmart 4
Description: Wearable sensor to record; sleep, stress, heart rate etc.

Intervention type: DEVICE
Intervention: mema - ilumivu
Description: mEMA is the a self-service platform running on both iOS and Android that is specifically designed for the administration of mobile Ecological Momentary Assessment or Experience Sampling research studies.

Intervention type: DEVICE
Intervention: mema - ilumivu
Description: mEMA is the a self-service platform running on both iOS and Android that is specifically designed for the administration of mobile Ecological Momentary Assessment or Experience Sampling research studies.
Study: NCT05174000

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Test Euthyrox®
Description: Participants will receive single oral dose of Test Euthyrox® either in treatment period 1, 2, 3 or 4.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Test Euthyrox®
Description: Participants will receive single oral dose of Test Euthyrox® either in treatment period 1, 2, 3 or 4.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Reference Euthyrox®
Description: Participants will receive single oral dose of Reference Euthyrox® either in treatment period 1, 2, 3 or 4.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Reference Euthyrox®
Description: Participants will receive single oral dose of Reference Euthyrox® either in treatment period 1, 2, 3 or 4.
Study: NCT06501703

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instruments
Description: instruments used as different techniques in final irrigation after root canal preparation

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Instruments
Description: instruments used as different techniques in final irrigation after root canal preparation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instruments
Description: instruments used as different techniques in final irrigation after root canal preparation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instruments
Description: instruments used as different techniques in final irrigation after root canal preparation
Study: NCT06149598

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coughing at the time of biopsy
Description: Patients are asked to cough or not to cough during cervical biopsy.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Coughing at the time of biopsy
Description: Patients are asked to cough or not to cough during cervical biopsy.
Study: NCT06429930

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L608 Liposomal inhalation solution
Description: Participants will be randomized at a ratio of 1:1 (for sentinel dosing) followed by 5:1 for the rest of the cohort to receive the assigned dose of L608 or placebo.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Solution
Description: Participants will be randomized at a ratio of 1:1 (for sentinel dosing) followed by 5:1 for the rest of the cohort to receive the assigned dose of L608 or placebo.
Study: NCT06114173

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cardunilizumab
Description: Cardunolizumab 6mg/kg was administered every 2 weeks, with the first evaluation at 8 weeks of treatment and subsequent evaluations every 12 weeks.
Study: NCT06282003

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: The procedure of protective lung ventilation
Description: The procedure of protective lung ventilation in the PV group of patients included preoxygenation with 60% oxygen in a mixture with air for 3 min, which maintained the target peripheral oxygen saturation at values above 94%, endotracheal intubation, volume-controlled mechanical ventilation, a tidal volume of 6 ml per kg of body weight. Normocarbia during the protective ventilation procedure was maintained by adjusting the minute ventilation, which is the product of the respiratory rate (12-14 breaths per minute) and the tidal volume set to 6 ml/kg of body weight. The most critical variable for the adjustment was the inhalation-exhalation ratio of 1:2, which ensured adequate oxygenation and removal of carbon dioxide during anesthesia. Identically as in the PV group, the target peripheral saturation was kept above 94% with an inspiratory oxygen concentration of 50% and peak airway pressure values of up to 40 kPa.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: The procedure of protective lung ventilation
Description: The procedure of protective lung ventilation in the PV group of patients included preoxygenation with 60% oxygen in a mixture with air for 3 min, which maintained the target peripheral oxygen saturation at values above 94%, endotracheal intubation, volume-controlled mechanical ventilation, a tidal volume of 6 ml per kg of body weight. Normocarbia during the protective ventilation procedure was maintained by adjusting the minute ventilation, which is the product of the respiratory rate (12-14 breaths per minute) and the tidal volume set to 6 ml/kg of body weight. The most critical variable for the adjustment was the inhalation-exhalation ratio of 1:2, which ensured adequate oxygenation and removal of carbon dioxide during anesthesia. Identically as in the PV group, the target peripheral saturation was kept above 94% with an inspiratory oxygen concentration of 50% and peak airway pressure values of up to 40 kPa.
Study: NCT04783636

Intervention type: DRUG
Group type: OTHER
Intervention: leuprorelin acetate 3.75mg
Description: PT105, PT105R

Intervention type: DRUG
Group type: OTHER
Intervention: leuprorelin acetate 3.75mg
Description: PT105, PT105R
Study: NCT04991766

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [¹⁴C]-LY3484356
Description: Administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3484356
Description: Administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [¹⁴C]-LY3484356 (IV)
Description: Administered IV.
Study: NCT06451432

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous Inguinal Ring Suturing (PIRS) technique
Description: Percutaneous Inguinal Ring Suturing (PIRS) technique
Study: NCT05094518

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile phone reminders
Description: Appointment reminders in the form of push notifications will be sent through HERA app.
Study: NCT06095648

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dose of platelet transfusion
Description: Intervention is using a lower (5ml/kg) compared to usual (15ml/kg) dose of platelets for transfusion in non-bleeding babies born at or before 32 weeks in NICU

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dose of platelet transfusion
Description: Intervention is using a lower (5ml/kg) compared to usual (15ml/kg) dose of platelets for transfusion in non-bleeding babies born at or before 32 weeks in NICU
Study: NCT05629325

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buspirone Hydrochloride 10 MG
Description: 4 weeks of treatment with buspirone

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buspirone Hydrochloride 10 MG
Description: 4 weeks of treatment with buspirone

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 4 weeks of treatment with placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 4 weeks of treatment with placebo
Study: NCT05354323

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NECVAX-NEO1
Description: Oral Ty21a based T-cell vaccination, personalized patient-individual NECVAX-NEO1 constructs containing a eukaryotic expression plasmid encoding for a series of selected neoantigen epitopes
Study: NCT06213727

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lowe-dose ZKY001 eye drops
Description: eye drops

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Medium-dose ZKY001 eye drops
Description: eye drops

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ZKY001 simulated eye drops
Description: eye drops
Study: NCT05403983

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga movement intervention
Description: Mixture of yoga, tai chi, pilates. Will be delivered in person (experimental) and online (active comparator)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Yoga movement intervention
Description: Mixture of yoga, tai chi, pilates. Will be delivered in person (experimental) and online (active comparator)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Education booklet
Description: Recently published postpartum physical activity guidebook through the Sport Information Resource Center of Canada
Study: NCT05550155

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment
Description: a 4-month maintenance procedure of active rTMS

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: a 4-month maintenance procedure of sham rTMS
Study: NCT05624008

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bioceramic glass ionomer restoration
Description: bioactive glass ionomer with unique biocompatibility and biological regenerative properties

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Resin modified glass ionomer restoration
Description: A hybrid of glass ionomer and composite resin with acid-base and polymerizable components
Study: NCT05722379

Intervention type: PROCEDURE
Intervention: left bundle branch pacing (LBBP)
Description: After recording the His potential, the 3830-69 lead (Medtronic Inc., Minneapolis, MN USA) was sent 1-2 cm forward and downward to find the insertion point of the right side of intra-ventricular septum combined with the pre-rotation impedance and ECG changes. Ultimately, the tip was perpendicularly straightforward posited against the septum to the left septal side .

Intervention type: PROCEDURE
Intervention: Right ventricular pacing (RVP)
Description: Right ventricular pacing (RVP) is the standard treatment for patients with continuous ventricular pacing needs.
Study: NCT05070884

Intervention type: OTHER
Intervention: The development of new clinical AI solutions to predict treatment response to neoadjuvant chemotherapy (NAC) in breast cancer
Description: Evaluate response to neoadjuvant treatment in advanced breast cancer
Study: NCT06297278

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Moderate Intensity Exercise
Description: Participants randomized to the active (moderate intensity) exercise condition will complete a 3-minute warm-up at low speed on a treadmill. Speed and incline will be increased in 3-minute increments until moderate-intensity exercise, defined as participants staying within a zone of 60-80% AAMHR with the target being to attain and maintain 70-75% AAMHR while briskly walking and/or jogging depending on current fitness status, is reached for a total of 30 min.
Study: NCT05241977

Intervention type: PROCEDURE
Intervention: anterior supra scapular nerve block
Description: nerve block for postoperative pain
Study: NCT05219916

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood collection.
Description: One additional 80 mL blood collection will be collected from HIV patients during a scheduled blood collection as part of their regular follow-up.~Samples will be transported within 3-5 hours by a carrier approved for the transportation of infectious biological samples from the Croix Rousse hospital to the P3 laboratory of the Ecole Normale Supérieure, Lyon for analysis.
Study: NCT06548711

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Transcutaneous Acupoint Electrical Stimulation (TAES)
Description: Transcutaneous acupoint electrical stimulation (TAES) is a non-invasive treatment method that delivers gentle electrical pulses through the skin to specific acupuncture points on the body. This technique aims to mimic the effects of traditional acupuncture, providing a convenient and painless method of treatment.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transcutaneous Acupoint Electrical Stimulation (TAES)
Description: Transcutaneous acupoint electrical stimulation (TAES) is a non-invasive treatment method that delivers gentle electrical pulses through the skin to specific acupuncture points on the body. This technique aims to mimic the effects of traditional acupuncture, providing a convenient and painless method of treatment.
Study: NCT06207266

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: emotion intelligence program
Description: The programme was established using research that described emotional intelligence components and their applicability to patients suffering from substance abuse. it considers as awareness program.
Study: NCT05458336

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nasal lavages with Tonimer Panthexyl®
Description: At the moment of diagnosis, patients were asked to fill out an ad hoc questionnaire to subjectively evaluate symptoms and comorbidities at the moment of diagnosis and of negativization. Subjects performed a daily nasal swab. When the subjects tested negative for the first time, they had to complete the questionnaire once again. Patients were given nasal washes (Tonimer Panthexyl®) to be performed three times a day, and in any case after nasal swab.
Study: NCT06228677

Intervention type: PROCEDURE
Intervention: Selective adrenal artery embolization
Description: Percutaneous selective adrenal artery embolization in patients with primary aldosteronism

Intervention type: PROCEDURE
Intervention: Selective adrenal artery embolization
Description: Percutaneous selective adrenal artery embolization in patients with primary aldosteronism
Study: NCT06171841

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: low-intensity resistance training
Description: 4 sets of 30/15/15/15 repetitions of leg press exercise with a load of 20-30% of one-repetition maximum (weeks 1-3: 20%, weeks 4-6: 30%) in normoxic conditions performed twice a week for 6 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: high-intensity resistance training
Description: 4 sets of 10 repetitions of leg press exercise at 70-80% one-repetition maximum (weeks 1-3: 70%, weeks 4-6: 80%) in normoxic conditions performed twice a week for 6 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low-intensity resistance training combined with blood flow restriction
Description: 4 sets of 30/15/15/15 repetitions of leg press exercise with a load of 20-30% of one-repetition maximum (weeks 1-3: 20%, weeks 4-6: 30%) in normoxic conditions with lower-limbs blood flow restriction (80% total occlusion pressure) performed twice a week for 6 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low-intensity resistance training in hypoxia condition
Description: 4 sets of 30/15/15/15 repetitions of leg press exercise with a load of 20-30% of one-repetition maximum (weeks 1-3: 20%, weeks 4-6: 30%) in hypoxia conditions (3500 meters above sea) performed twice a week for 6 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low-intensity resistance training combined with blood flow restriction in hypoxia condition
Description: 4 sets of 30/15/15/15 repetitions of leg press exercise with a load of 20-30% of one-repetition maximum (weeks 1-3: 20%, weeks 4-6: 30%) in normobaric hypoxia conditions (3500 meters above sea) with lower-limbs blood flow restriction (80% total occlusion pressure) performed twice a week for 6 weeks.
Study: NCT04988100

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: splenic artery ligation
Description: Splenic artery will be ligated just after takeoff from coeliac trunk at the level of body of pancreas

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: No intervention
Description: Splenic artery is not ligated despite the presence of portal hyperperfusion
Study: NCT06334094

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ozanimod
Description: A hard capsule that is taken daily for one year.
Study: NCT05790278

Intervention type: OTHER
Intervention: Survey
Description: Completion of a Purpose in Life Survey

Intervention type: OTHER
Intervention: Survey
Description: Completion of a Purpose in Life Survey

Intervention type: OTHER
Intervention: Survey
Description: Completion of a Purpose in Life Survey
Study: NCT05680987

Intervention type: PROCEDURE
Group type: OTHER
Intervention: RFN-Advanced Retrograde Femoral Nailing System
Description: RFN-Advanced Retrograde Femoral Nailing System for patients with a distal femur or femoral shaft fracture requiring surgery